Literature DB >> 21118687

Effect of repetitiveness on the immunogenicity and antigenicity of Trypanosoma cruzi FRA protein.

Ariel A Valiente-Gabioud1, Carolina Veaute, Melina Perrig, Félix S Galan-Romano, Silvano J Sferco, Iván S Marcipar.   

Abstract

Repetitive proteins (RP) of Trypanosoma cruzi are highly present in the parasite and are strongly recognized by sera from Chagas' disease patients. Flagelar Repetitive Antigen (FRA), which is expressed in all steps of the parasite life cycle, is the RP that displays the greatest number of aminoacids per repeat and has been indicated as one of the most suitable candidate for diagnostic test because of its high performance in immunoassays. Here we analyzed the influence of the number of repeats on the immunogenic and antigenic properties of the antigen. Recombinant proteins containing one, two, and four tandem repeats of FRA (FRA1, FRA2, and FRA4, respectively) were obtained and the immune response induced by an equal amount of repeats was evaluated in a mouse model. The reactivity of specific antibodies present in sera from patients naturally infected with T. cruzi was also assessed against FRA1, FRA2, and FRA4 proteins, and the relative avidity was analyzed. We determined that the number of repeats did not increase the humoral response against the antigen and this result was reproduced when the repeated motifs were alone or fused to a non-repetitive protein. By contrast, the binding affinity of specific human antibodies increases with the number of repeated motifs in FRA antigen. We then concluded that the high ability of FRA to be recognized by specific antibodies from infected individuals is mainly due to a favorable polyvalent interaction between the antigen and the antibodies. In accordance with experimental results, a 3D model was proposed and B epitope in FRA1, FRA2, and FRA4 were predicted.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21118687     DOI: 10.1016/j.exppara.2010.11.011

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  13 in total

1.  A TeGM6-4r antigen-based immunochromatographic test (ICT) for animal trypanosomosis.

Authors:  Thu-Thuy Nguyen; Ngasaman Ruttayaporn; Yasuyuki Goto; Shin-ichiro Kawazu; Tatsuya Sakurai; Noboru Inoue
Journal:  Parasitol Res       Date:  2015-08-21       Impact factor: 2.289

2.  Tandem repeat protein as potential diagnostic antigen for Trypanosoma evansi infection.

Authors:  Nguyen Thu Thuy; Yasuyuki Goto; Zhao-Rong Lun; Shin-Ichiro Kawazu; Noboru Inoue
Journal:  Parasitol Res       Date:  2011-09-17       Impact factor: 2.289

3.  A Study of Cross-Reactivity Between Recombinant EPC1 Antigen of Echinococcus granulosus in Serum from Patients with Confirmed Cystic Echinococcosis Infection and Other Parasitic Infections.

Authors:  Saeid Fathi; Fatemeh Jalousian; Seyed Hossein Hosseini; Hossein Parsa; Somayeh Kordafshari
Journal:  Am J Trop Med Hyg       Date:  2016-04-18       Impact factor: 2.345

4.  Improved serodiagnosis of cystic echinococcosis using the new recombinant 2B2t antigen.

Authors:  Ana Hernández-González; Saúl Santivañez; Héctor H García; Silvia Rodríguez; Santiago Muñoz; Guillermo Ramos; Antonio Orduña; Mar Siles-Lucas
Journal:  PLoS Negl Trop Dis       Date:  2012-07-03

5.  Epitope reactions can be gauged by relative antibody discriminating specificity (RADS) values supported by deletion, substitution and cysteine bridge formation analyses: potential uses in pathogenesis studies.

Authors:  Andrew K I Falconar
Journal:  BMC Res Notes       Date:  2012-07-05

6.  Identification of strain-specific B-cell epitopes in Trypanosoma cruzi using genome-scale epitope prediction and high-throughput immunoscreening with peptide arrays.

Authors:  Tiago Antônio de Oliveira Mendes; João Luís Reis Cunha; Rodrigo de Almeida Lourdes; Gabriela Flávia Rodrigues Luiz; Lucas Dhom Lemos; Ana Rita Rocha dos Santos; Antônia Cláudia Jácome da Câmara; Lúcia Maria da Cunha Galvão; Caryn Bern; Robert H Gilman; Ricardo Toshio Fujiwara; Ricardo Tostes Gazzinelli; Daniella Castanheira Bartholomeu
Journal:  PLoS Negl Trop Dis       Date:  2013-10-31

7.  Evaluation of a new set of recombinant antigens for the serological diagnosis of human and canine visceral leishmaniasis.

Authors:  Franklin B Magalhães; Artur L Castro Neto; Marilia B Nascimento; Wagner J T Santos; Zulma M Medeiros; Adelino S Lima Neto; Dorcas L Costa; Carlos H N Costa; Washington L C Dos Santos; Lain C Pontes de Carvalho; Geraldo G S Oliveira; Osvaldo P de Melo Neto
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

8.  A refined genome phage display methodology delineates the human antibody response in patients with Chagas disease.

Authors:  André Azevedo Reis Teixeira; Luis Rodriguez Carnero; Andréia Kuramoto; Fenny Hui Fen Tang; Carlos Hernique Gomes; Natalia Bueno Pereira; Léa Campos de Oliveira; Regina Garrini; Jhonatas Sirino Monteiro; João Carlos Setubal; Ester Cerdeira Sabino; Renata Pasqualini; Walter Colli; Wadih Arap; Maria Júlia Manso Alves; Edécio Cunha-Neto; Ricardo José Giordano
Journal:  iScience       Date:  2021-05-15

9.  The MASP family of Trypanosoma cruzi: changes in gene expression and antigenic profile during the acute phase of experimental infection.

Authors:  Sara Lopes dos Santos; Leandro Martins Freitas; Francisco Pereira Lobo; Gabriela Flávia Rodrigues-Luiz; Tiago Antônio de Oliveira Mendes; Anny Carolline Silva Oliveira; Luciana Oliveira Andrade; Egler Chiari; Ricardo Tostes Gazzinelli; Santuza Maria Ribeiro Teixeira; Ricardo Toshio Fujiwara; Daniella Castanheira Bartholomeu
Journal:  PLoS Negl Trop Dis       Date:  2012-08-14

10.  Chagas disease-specific antigens: characterization of epitopes in CRA/FRA by synthetic peptide mapping and evaluation by ELISA-peptide assay.

Authors:  Carolina G Bottino; Luciano P Gomes; José B Pereira; José R Coura; David William Provance; Salvatore G De-Simone
Journal:  BMC Infect Dis       Date:  2013-12-03       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.